Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.95
+0.34 (4.47%)
Sep 5, 2025, 3:18 PM - Market open
Arvinas Market Cap
Arvinas has a market cap or net worth of $583.67 million as of September 5, 2025. Its market cap has decreased by -66.59% in one year.
Market Cap
583.67M
Enterprise Value
-286.72M
1-Year Change
-66.59%
Ranking
Category
Stock Price
$7.95
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $583.67M, an increase of 13.08%. That is a compound annual growth rate of 1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 558.71M | -57.58% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | 4.09B | 159.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |